Driving Supply Chain Visibility in Pharmaceutical and Life Sciences Industry with Data Analytics: Part 1 of 2

The pharmaceutical and life sciences supply chain has undergone enormous changes over the last couple of centuries. And with each change, the extent of complexity has increasingly become more. 

In the 19th century, the supply chain was very localized – products were manufactured and consumed in a very small geographical area. In the beginning of the 20th century, globalization and advancements in transportation and storage allowed companies to distribute products over a much larger geographical areaWith this change came new challenges such as longer lead times, increased risk of delays, and greater exposure to geopolitical disruptions.

In the mid-20th century, agencies like the U.S. Food and Drug Administration and the European Medicines Agency brought sharp focus on regulatory compliance and quality control. As a result, Good Manufacturing Practices and Good Distribution Practices were established, which brought in increased transparency and control over the movement of products This added complexity and cost to the supply chain, as companies had to make investments in infrastructure upgrades to meet regulatory compliance.

In more recent times, outsourcing and offshoring of manufacturing to low-cost countries in the Asian region has introduced increased lead times, more dependency on external suppliers, and higher exposure to geopolitical tensions. Additionally, disruptions such as natural disasters, pandemics, or port delays in supplier regions now have a more pronounced ripple effect across globalized supply chain.

With all these changes, the supply chain function in pharmaceutical and life sciences companies currently faces the following pressing challenges: 

  • High drug approval timelines (12-18 months) 
  • Surge in raw material cost (~22% since 2022) 
  • Talent gap in digital logistics and advanced therapy production areas 
  • Significant annual loss (~$35 billiondue to temperature-related issues 
  • Waste of ~$8 billion worth of biologics every year due to customer delays 
 

Amidst this scenario, the ability to track, monitor, and analyze the data throughout the supply chain – from supplying raw materials to manufacturing, distribution, and final delivery to hospitals, pharmacies, or patients – has become a key need for pharmaceutical and life sciences companies to tackle these challengesThis ability, called ‘Supply Chain Visibility,’ helps companies get a real-time, end-to-end view of their supply chain network. 

In this blog, we will discuss the role of data analytics in providing ‘Supply Chain Visibility’ to pharmaceutical and life sciences companies. 

Two Segments of Supply Chain

The supply chain ecosystem can broadly be divided into two interdependent yet distinct segments: The first segment is ‘supply chain planning,’ which deals with identifying the actions that need to be taken to establish an efficient and effective supply chain. The second segment is ‘supply chain execution which deals with actual execution of the steps identified during ‘supply chain planning stage.

This blog is in a two-part series. In this (1st part) partwe’ll explore the role of data analytics in driving visibility in ‘supply chain planning’ segment.  In the next blog, we’ll focus on how data analytics drives visibility across ‘supply chain execution’ segment. 

Technologies Driving Supply Chain Visibility

Several technology solutions are crucial for enabling robust supply chain visibility in the pharmaceutical and life sciences industry. These technologies work in concert to provide real-time data, enhance decision-making, and improve overall supply chain performance. The top five technology solutions include:

 

 

  • Track and Trace Systems: These systems utilize technologies like serialization, radio frequency identification, and barcode scanning to track products throughout the supply chain.
  • Internet of Things Devices: Sensors and devices embedded in packaging and transportation units monitor critical environmental factors such as temperature, humidity, and location, ensuring product integrity, especially for temperature-sensitive pharmaceuticals.
  • Cloud-Based Platforms: Cloud computing provides a centralized platform for data storage, processing, and sharing, enabling real-time collaboration and access to information across the supply chain.
  • Blockchain Technology: Blockchain enhances transparency and security by creating an immutable record of transactions, improving traceability and combating counterfeiting.
  • Data Analytics: Data analytics leverages advanced algorithms and machine learning to analyze the vast amounts of data generated by the other technologies. This analysis provides actionable insights into supply chain performance, identifies potential risks and inefficiencies, and supports data-driven decision-making for optimized operations and improved resilience. 

Among the above-mentioned technologies, data analytics acts as the intelligence layer – interpreting signals from IoT devices, identifying patterns across cloud supply chain management platforms, informing AI models, and validating blockchain records. In doing so, it augments supply chain visibility by acting as the backbone that integrates data from various sources and provides a single source of truth across the entire supply chain. 

DiLytics Prebuilt Supply Chain Planning Insight Solution

DiLytics has built a supply chain planning solution, branded as DiLytics Supply Chain Planning Insight Solution, that provides the above-mentioned functionalities/capabilities for the pharmaceutical and life sciences industry This solution comes with: 

  • Industryleading data model 
  • Data pipelines from leading ERPs 
  • A rich library of reportsdashboards, and metrics 
  • Conversational interface  

A high-level architecture of DiLytics Supply Chain Planning Insight Solution is provided below: 

Data-Driven Organizations Are 3x More Likely to Achieve Better Business Outcomes

DiLytics helps organizations modernize analytics, improve decision-making, and turn complex data into a competitive advantage.

Conclusion

In the pharmaceutical and life sciences industry, where strict regulation, supply disruptions, and demand volatility are common, data analytics provides a potent mechanism to obtain end-to-end supply chain visibility. By breaking down data silos and leveraging advanced analytical techniques, companies can move from reacting to problems to predicting and preventing themLeveraging these capabilities will empower companies to manage volatility better, minimize risks, reduce costs, and build a resilient supply chain. The future of the supply chain is data-driven, and visibility is at its core. 

Leave a Reply

Your email address will not be published. Required fields are marked *